share_log

Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON GLYNN

SEC ·  Jan 19 13:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more